GLENVIEW, Ill., Dec 25, 2011 (BUSINESS WIRE) --Mead Johnson Nutrition (NYSE: MJN) has conducted a new round of rigorous
testing on samples of a batch of Enfamil Premium(R) Newborn powdered
formula related to a U.S. Food & Drug Administration (FDA)
investigation. Drawn from samples parallel to those being tested by
public health officials and following the same methodology, the new
testing did not detect any presence of Cronobacter (Enterobacter
sakazakii).
These new results reaffirm the testing conducted before the batch was
made available to retailers and consumers. Based on both sets of tests,
Mead Johnson can say with confidence that Enfamil Premium Newborn
formula, like every infant formula the company produces, is safe.
The company undertook the highly unusual retesting due to continuing
misinformation and confusion in the marketplace. Mead Johnson recognizes
that parents and health care professionals trust and rely on the Enfamil
brand and takes that responsibility very seriously. The company wanted
to reassure consumers - as quickly as possible and based on rigorous
scientific data - of the safety and quality of all its products.
These results are consistent with independent media accounts from
Reuters, CNN, the Associated Press and others, reporting that none of
the formula samples relating to the case have tested positive.
The U.S. FDA and the U.S. Centers for Disease Control are seeking to
determine the origin of the Cronobacter involved in the Missouri
case and are expected to be testing a variety of possible environmental
sources. The company has shared the results from its two tests with both
authorities.
All Mead Johnson infant formulas undergo more than 2,300 quality tests
and checks to ensure that they meet or exceed all standards set by
regulatory bodies, including the World Health Organization and the U.S.
FDA.
As always, Mead Johnson remains committed to its mission to nourish the
world's children for the best start in life.
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over 50
markets worldwide. The company's mission is to nourish the world's
children for the best start in life. The Mead Johnson name has been
associated with science-based pediatric nutrition products for over 100
years. The company's "Enfa" family of brands, including Enfamil(R)
infant formula, is the world's leading brand franchise in pediatric
nutrition.
For more information on the company, go to meadjohnson.com.
SOURCE: Mead Johnson Nutrition
Mead Johnson Nutrition
Media: Christopher Perille, 847-224-9414
chris.perille@mjn.com
or
Investors: Kathy MacDonald, 847-832-2182
kathy.macdonald@mjn.com